210
Participants
Start Date
March 26, 2021
Primary Completion Date
October 30, 2023
Study Completion Date
November 13, 2023
vafidemstat
1.2mg capsule
Placebo
placebo capsule
Medical Center Intermedika, Sofia
Clinical center Kragujevac, Kragujevac
Medical Center Hera EOOD - Psychiatry Office, Sofia
"DCC Mladost-M Ltd, Psychiatr", Varna
The Medical Research Network, New York
Emovis GmbH, Berlin
"Clinic for psychiatric disorders Laza Lazarevic", Belgrade
Clinical center of Serbia, Belgrade
Neurobehavioral Research Inc., Cedarhurst
Hospital Clínico San Carlos, Madrid
New Life Medical Research Center, Hialeah
Phoenix Medical Research LLC, Miami
Revive Research Institute, Elgin
Klinik fur Psychiatrie und Psychotherapie, LMU, München
Excell Research Inc, Oceanside
Excell Research, Inc., Oceanside
Core Clinical Research, Everett
University of Chicago Institutional Review Board, Chicago
Adams Clinical Trials, LLC, Watertown
Center for Emotioal Fitness, Cherry Hill
Hospital Vall d'Hebron, Barcelona
Lead Sponsor
Oryzon Genomics S.A.
INDUSTRY